[Journal logo]

Volume 66 
Part 11 
Pages m1490-m1491  
November 2010  

Received 21 October 2010
Accepted 23 October 2010
Online 31 October 2010

Key indicators
Single-crystal X-ray study
T = 295 K
Mean [sigma](C-C) = 0.009 Å
R = 0.044
wR = 0.135
Data-to-parameter ratio = 12.4
Details
Open access

Poly[[[[1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylato]cadmium]-[mu]-benzene-1,4-dicarboxylato] trihydrate]

aSchool of Pharmacological Sciences, Xinjiang Medical University, Urumqi 830054, People's Republic of China, and bSchool of Chemistry and Life Science, Guangdong University of Petrochemical Technology, Maoming 525000, People's Republic of China
Correspondence e-mail: kasimu_xmu@163.com

In the title layered coordination polymer, {[Cd(C17H18F2N3O3)(C8H4O4)]·3H2O}n, the CdII atom exhibits a very distorted CdO6 octahedral geometry defined by one O3,O4-bidentate 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (lome) ligand, one O,O'-bidentate benzene-1,4-dicarboxylate (bdc) dianion and two O-monodentate bdc dianions. Both the bdc species in the asymmetric unit are completed by crystallographic inversion symmetry. The bridging bdc dianions link the cadmium nodes into a rectangular grid lying parallel to (01[\overline{1}]). A network of N-H...O and O-H...O hydrogen bonds helps to establish the packing.

Related literature

For background on the medicinal uses of lomefloxacin, see: Mizuki et al. (1996[Mizuki, Y., Fujiwara, I. & Yamaguchi, T. (1996). J. Antimicrob. Chemother. 37 (Suppl. A), 41-45.]).

[Scheme 1]

Experimental

Crystal data
  • [Cd(C17H18F2N3O3)(C8H4O4)]·3H2O

  • Mr = 680.90

  • Triclinic, [P \overline 1]

  • a = 9.7924 (7) Å

  • b = 11.9788 (8) Å

  • c = 13.3981 (9) Å

  • [alpha] = 114.138 (1)°

  • [beta] = 103.430 (1)°

  • [gamma] = 100.295 (1)°

  • V = 1327.00 (16) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.90 mm-1

  • T = 295 K

  • 0.32 × 0.24 × 0.18 mm

Data collection
  • Bruker SMART CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2001[Bruker (2001). SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.762, Tmax = 0.855

  • 6581 measured reflections

  • 4624 independent reflections

  • 4108 reflections with I > 2[sigma](I)

  • Rint = 0.014

Refinement
  • R[F2 > 2[sigma](F2)] = 0.044

  • wR(F2) = 0.135

  • S = 1.11

  • 4624 reflections

  • 372 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 1.76 e Å-3

  • [Delta][rho]min = -0.81 e Å-3

Table 1
Selected bond lengths (Å)

Cd1-O6 2.213 (4)
Cd1-O3 2.238 (3)
Cd1-O7i 2.295 (4)
Cd1-O1 2.299 (4)
Cd1-O5 2.322 (4)
Cd1-O4 2.510 (4)
Symmetry code: (i) -x+1, -y+1, -z+1.

Table 2
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N3-H3A...O8 0.86 2.33 2.749 (8) 110
O8-H8A...O2ii 0.85 2.02 2.854 (7) 166
O8-H8B...O4iii 0.85 2.01 2.837 (7) 166
O9-H9B...O10iv 0.85 1.84 2.687 (14) 178
O9-H9A...O5v 0.85 1.93 2.784 (9) 178
O10-H5O...O2 0.85 2.13 2.971 (10) 171
O10-H6O...O9 0.85 2.42 2.957 (14) 121
Symmetry codes: (ii) -x+2, -y, -z+1; (iii) x, y-1, z-1; (iv) -x+1, -y, -z+2; (v) x, y-1, z.

Data collection: APEX2 (Bruker, 2004[Bruker (2004). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT-Plus (Bruker, 2001[Bruker (2001). SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB5699 ).


Acknowledgements

The authors acknowledge financial support from Xinjiang Medical University and Guangdong University of Petrochemical Technology.

References

Bruker (2001). SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2004). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.
Mizuki, Y., Fujiwara, I. & Yamaguchi, T. (1996). J. Antimicrob. Chemother. 37 (Suppl. A), 41-45.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]


Acta Cryst (2010). E66, m1490-m1491   [ doi:10.1107/S160053681004328X ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.